Airway Medix S.A. va obtenir 2 millions d’euros pour le développement et la commercialisation de ses projets
Airway Medix a signé deux accords d’investissement avec CoOpera, Kröner Medizintechnik et un groupe suisse, pour un montant pouvant atteindre 2 millions d’euros. Les fonds sont consacrés au développement et à la commercialisation des trois produits brevetés de l’entreprise.
Texte intégral en anglais (original)
Warsaw, November 16, 2023: Airway Medix has signed two Investment Agreements with CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. Partners will invest up to EUR 2 million, enabling the continuation of commercialization of innovative medical products on the EU, US, Asian and South American markets.
Three finished products, with international patents, focus on supporting patients' mechanical ventilation. Kröner Medizintechnik, CEO Peter Kröner, will be operationally and strategically involved in the company's development, covering production processes.
The partners, using their experience in the medical industry, granted the Company a EUR 900,000 loan, enabling it to complete negotiations and start business talks. The goal is to quickly commercialize products and develop synergies with partners' experience in the distribution of medical equipment.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Les communiqués de presse sont publiés tels qu’émis par Airway Medix S.A. Les informations sur les produits s’appuient sur la notice d’utilisation.
